Relmada Therapeutics Inc (NAS:RLMD)
$ 3.32 -0.1 (-2.92%) Market Cap: 100.18 Mil Enterprise Value: 33.36 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 34/100

Relmada Therapeutics Inc (RLMD) Transcripts

  • 1